Skip to search formSkip to main contentSkip to account menu

TOL101

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Antibodies, Monoclonal, Murine-Derived

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
First‐in‐Human Study of the Safety and Efficacy of TOL101 Induction to Prevent Kidney Transplant Rejection
TOL101 is a murine IgM mAb targeting the αβ TCR. Unlike other T cell targets, the αβ TCR has no known intracellular signaling… 
2014
2014
Clinical trials: Human antibody-mediated T-cell suppression for kidney transplantation
Suppression of acute cellular alloimmunity, without eliciting adverse reactions, is vital to the overall outcome of kidney… 
2014
2014
The Pharmacokinetics & Pharmacodynamics of TOL101, a Murine IgM Anti-Human alpha beta T Cell Receptor Antibody in Renal Transplant Patients.: Abstract# C1818
2012
2012
First in Man Evaluation of the Safety and Potential Efficacy of TOL101 Induction to Prevent Kidney Transplant Rejection: 434
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)